NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,827 | -1.6% | 3,529 | +30.1% | 0.00% | 0.0% |
| Q2 2023 | $68,964 | -29.7% | 2,713 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $98,075 | -7.2% | 2,713 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $105,698 | -16.1% | 2,713 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $126,000 | +6.8% | 2,713 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $118,000 | -39.8% | 2,713 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $196,000 | -10.9% | 2,713 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $220,000 | -30.4% | 2,713 | 0.0% | 0.01% | -41.7% |
| Q3 2021 | $316,000 | -29.8% | 2,713 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $450,000 | +16.6% | 2,713 | -1.9% | 0.02% | +6.7% |
| Q1 2021 | $386,000 | -22.0% | 2,766 | -3.3% | 0.02% | -34.8% |
| Q4 2020 | $495,000 | +24.1% | 2,861 | 0.0% | 0.02% | +27.8% |
| Q3 2020 | $399,000 | +12.7% | 2,861 | -3.5% | 0.02% | +5.9% |
| Q2 2020 | $354,000 | +32.6% | 2,966 | +11.0% | 0.02% | +13.3% |
| Q1 2020 | $267,000 | -13.0% | 2,673 | +2.3% | 0.02% | +7.1% |
| Q4 2019 | $307,000 | +46.9% | 2,612 | +7.4% | 0.01% | +40.0% |
| Q3 2019 | $209,000 | +32.3% | 2,432 | 0.0% | 0.01% | +42.9% |
| Q2 2019 | $158,000 | +3.9% | 2,432 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $152,000 | +60.0% | 2,432 | 0.0% | 0.01% | +40.0% |
| Q4 2018 | $95,000 | -31.7% | 2,432 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $139,000 | -28.4% | 2,432 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $194,000 | -8.1% | 2,432 | 0.0% | 0.01% | -10.0% |
| Q1 2018 | $211,000 | +25.6% | 2,432 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $168,000 | -19.6% | 2,432 | 0.0% | 0.01% | -20.0% |
| Q3 2017 | $209,000 | +15.5% | 2,432 | 0.0% | 0.01% | +11.1% |
| Q2 2017 | $181,000 | -6.7% | 2,432 | +17.3% | 0.01% | -10.0% |
| Q1 2017 | $194,000 | -10.6% | 2,074 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $217,000 | – | 2,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |